
Taurine (500mg) + Acetylcysteine (150mg)
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Glomosafe Tablet is a pharmaceutical formulation combining Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and promote antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a crucial role in osmoregulation, membrane stabilization, and modulation of calcium signaling, contributing to cardiovascular and neurological function. Acetylcysteine, a well-known mucolytic agent and precursor to glutathione, enhances the body’s antioxidant capacity by replenishing intracellular glutathione stores, thereby mitigating oxidative stress and supporting detoxification processes. The synergistic action of Taurine and Acetylcysteine in Glomosafe Tablet aids in protecting cells from damage induced by free radicals and oxidative injury, which is beneficial in conditions associated with oxidative stress and impaired cellular metabolism. This combination may be indicated as an adjunctive therapy in chronic respiratory disorders, liver dysfunction, and metabolic syndromes where antioxidant support is warranted. Glomosafe Tablet should be administered under medical supervision, with dosage adjusted according to individual patient needs and clinical response. Caution is advised in patients with hypersensitivity to the components or underlying medical conditions. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Glomosafe Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Glomosafe Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Glomosafe Tablet is safe to use in patients with kidney disease. No dose adjustment of Glomosafe Tablet is recommended.
Exercise Caution
It is not known whether Glomosafe Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Glomosafe Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Glomosafe Tablet

Taurine (500mg) + Acetylcysteine (150mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Glomosafe Tablet is a pharmaceutical formulation combining Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and promote antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a crucial role in osmoregulation, membrane stabilization, and modulation of calcium signaling, contributing to cardiovascular and neurological function. Acetylcysteine, a well-known mucolytic agent and precursor to glutathione, enhances the body’s antioxidant capacity by replenishing intracellular glutathione stores, thereby mitigating oxidative stress and supporting detoxification processes. The synergistic action of Taurine and Acetylcysteine in Glomosafe Tablet aids in protecting cells from damage induced by free radicals and oxidative injury, which is beneficial in conditions associated with oxidative stress and impaired cellular metabolism. This combination may be indicated as an adjunctive therapy in chronic respiratory disorders, liver dysfunction, and metabolic syndromes where antioxidant support is warranted. Glomosafe Tablet should be administered under medical supervision, with dosage adjusted according to individual patient needs and clinical response. Caution is advised in patients with hypersensitivity to the components or underlying medical conditions. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Glomosafe Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Glomosafe Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Glomosafe Tablet is safe to use in patients with kidney disease. No dose adjustment of Glomosafe Tablet is recommended.
Exercise Caution
It is not known whether Glomosafe Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Glomosafe Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Glomosafe Tablet















